基本信息
浏览量:249
职业迁徙
个人简介
Dr. Miller is an internationally recognized expert on retinal disorders, including age-related macular degeneration (AMD). Over the last two decades, she and her colleagues at Mass. Eye and Ear/HMS pioneered the development of photodynamic therapy using verteporfin (Visudyne®), the first approved pharmacological therapy able to reduce and slow vision loss in patients with AMD. The group also identified the key role of vascular endothelial growth factor (VEGF) in ocular neovascularization, leading to the development of anti-VEGF therapies now administered to millions of children and adults with sight-threatening retinal diseases annually around the world. Dr. Miller’s current studies focus on the genetics of AMD, strategies for early intervention in AMD, neuroprotective therapies for retinal diseases, and MacTel and other maculopathies.
研究兴趣
论文共 830 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
OPHTHALMOLOGY SCIENCEno. 1 (2024): 100341-100341
JAMA OPHTHALMOLOGYno. 1 (2024): 48-52
Daniel M Vu,Tobias Elze,Joan W Miller,Alice C Lorch,Deborah K VanderVeen,Isdin Oke, IRIS® Registry Analytic Center Consortium
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
BRITISH JOURNAL OF OPHTHALMOLOGYpp.bjo-323507, (2023)
引用1浏览0引用
1
0
The British journal of ophthalmology (2023)
引用0浏览0WOS引用
0
0
Georgiy Kozak,Kevin Mendez,Gregory Tsougranis,Ines Lains, Hae Kang,Hanna Choi,Ivana Kim,Demetrios Vavvas,David Wu,Joan Miller,John Miller,Deeba Husain
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn